Syndecan-1/CD138 Antibody (DL-101) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-43972
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # DL-101
Concentration
5 mg/ml
Product Specifications
Immunogen
The immunogen for this antibody was CD138.
Reactivity Notes
This antibody is reactive to Human.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Scientific Data Images for Syndecan-1/CD138 Antibody (DL-101) [FITC]
Flow Cytometry: Syndecan-1/CD138 Antibody (DL-101) [FITC] [NBP1-43972] - Staining of the U266 cell line with Mouse IgG1 K Isotype Control FITC (blue histogram) or Anti-Human CD138 (Syndecan-1) FITC (purple histogram). Total viable cells, as determined by Fixable Viability Dye eFluor 660, were used for analysis.
Applications for Syndecan-1/CD138 Antibody (DL-101) [FITC]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
The DL-101 antibody has been tested by flow cytometric analysis of cell lines. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8cells/test.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) with 0.1% gelatin and 0.2%BSA
Preservative
0.09% Sodium Azide
Concentration
5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Syndecan-1/CD138
Alternate Names
CD138, SDC1, Syndecan1
Gene Symbol
SDC1
Additional Syndecan-1/CD138 Products
Product Documents for Syndecan-1/CD138 Antibody (DL-101) [FITC]
Product Specific Notices for Syndecan-1/CD138 Antibody (DL-101) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...